ATI Physical Therapy (ATIP)
(Delayed Data from NYSE)
$4.17 USD
0.00 (-0.05%)
Updated Apr 30, 2024 12:04 PM ET
After-Market: $4.15 -0.02 (-0.36%) 4:18 PM ET
5-Strong Sell of 5 5
C Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.17 USD
0.00 (-0.05%)
Updated Apr 30, 2024 12:04 PM ET
After-Market: $4.15 -0.02 (-0.36%) 4:18 PM ET
5-Strong Sell of 5 5
C Value A Growth C Momentum B VGM
Zacks News
Chemed (CHE) Q1 Earnings Miss Estimates
by Zacks Equity Research
Chemed (CHE) delivered earnings and revenue surprises of -4.94% and 0.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ATI Physical Therapy, Inc. (ATIP) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
ATI Physical Therapy, Inc. (ATIP) delivered earnings and revenue surprises of -351.43% and 1.27%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Amedisys (AMED) Tops Q2 Earnings Estimates
by Zacks Equity Research
Amedisys (AMED) delivered earnings and revenue surprises of 28.04% and 2.47%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
ATI Physical Therapy, Inc. (ATIP) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
ATI Physical Therapy, Inc. (ATIP) delivered earnings and revenue surprises of -87.50% and 4.67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for May 3rd
by Zacks Equity Research
ILLM, ATIP and AOMR have been added to the Zacks Rank #5 (Strong Sell) List on May 3, 2023.
Elanco Animal Health Incorporated (ELAN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Elanco Animal Health Incorporated (ELAN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate ATI Physical Therapy, Inc. (ATIP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
ATI Physical Therapy, Inc. (ATIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for April 26th
by Zacks Equity Research
KERN, ILLM and ATIP have been added to the Zacks Rank #5 (Strong Sell) List on April 26, 2023.
New Strong Sell Stocks for April 4th
by Zacks Equity Research
ATY, ASYS and ATIP have been added to the Zacks Rank #5 (Strong Sell) List on April 4, 2023.
New Strong Sell Stocks for March 31st
by Zacks Equity Research
ATY, ATIP and ASMIY have been added to the Zacks Rank #5 (Strong Sell) List on March 31, 2023.
New Strong Sell Stocks for March 28th
by Zacks Equity Research
ATY, ATIP and APA have been added to the Zacks Rank #5 (Strong Sell) List on March 28, 2023.
Strength Seen in LifeStance Health (LFST): Can Its 5.5% Jump Turn into More Strength?
by Zacks Equity Research
LifeStance Health (LFST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
ATI Physical Therapy, Inc. (ATIP) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
ATI Physical Therapy, Inc. (ATIP) delivered earnings and revenue surprises of 0% and 1.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ATI Physical Therapy, Inc. (ATIP) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
ATI Physical Therapy, Inc. (ATIP) delivered earnings and revenue surprises of -42.86% and 3.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Elanco Animal Health Incorporated (ELAN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Elanco Animal Health Incorporated (ELAN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will ATI Physical Therapy, Inc. (ATIP) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
ATI Physical Therapy, Inc. (ATIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why ATI Physical Therapy, Inc. (ATIP) Is a Great 'Buy the Bottom' Stock Now
by Zacks Equity Research
ATI Physical Therapy, Inc. (ATIP) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Is ATI Physical Therapy, Inc. (ATIP) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how ATI Physical Therapy, Inc. (ATIP) and Baxter International (BAX) have performed compared to their sector so far this year.